Clinical TrialsSearch results
Number of results: 340
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma:
the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Completed
- Preventive effects of Hangeshashinto for oral mucositis in Hematopoietic Stem Cell Transplantation Recipients
- Patients who will undergo allogeneic hematopoietic stem cell transplantation
- Yoshimatsu Masako
- 2020-05-07
Completed
- Usefulness of antimicrobial photodynamic therapy for chronic periodontitis
- Periodontitis
- Yamashita Yasunori
- 2019-11-15
Other
- Study of Safety and Tolerability of CFZ533 in Patients With Sjogren's Syndrome (TWINSS Extn)
- Sjogren's Syndrome
- Yamada Hiroyuki
- 2020-12-21
Other
- A randomized controlled Phase II study comparing TS-1 alone with CDDP+TS-1 as postoperative adjuvant chemotherapy in non-small-cell-lung-cancer ; translational research of the chemotherapy effect prediction factor
- Non Small Cell Lung Cancer
- West Japan Oncology Group
- 2009-01-26
Other
- A Randomized phase II study of docetaxel versus weekly
carboplatin and CPT-11
for previously treated Non-Small cell lung cancer
- second line chemotherapy for Non-Small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer.
- limited-disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-09